Maureen Hattersley

Identification of CCR2 and CD180 as Robust Pharmacodynamic Tumor and Blood Biomarkers for Clinical Use with BRD4/BET Inhibitors

Greg O'Connor, J Carl Barrett, A. Dulak, 2017, Clinical Cancer Research.